Effects of combined OncoTherad immunotherapy and probiotic supplementation on modulating the chronic inflammatory process in colorectal carcinogenesis-Reference-Cited by-同舟云学术

Effects of combined OncoTherad immunotherapy and probiotic supplementation on modulating the chronic inflammatory process in colorectal carcinogenesis

Published:2022-04 Issue: Volume:75 Page:101747
ISSN:0040-8166
Container-title:Tissue and Cell
language:en
Short-container-title:Tissue and Cell

Author:

Reis Sabrina Karen^ORCID,Socca Eduardo Augusto Rabelo,de Souza Bianca Ribeiro^ORCID,Genaro Sandra Cristina,Durán Nelson,Fávaro Wagner José^ORCID

Funder

Fundacao de Amparo a Pesquisa do Estado de Sao Paulo

Publisher

Elsevier BV

Subject

Cell Biology,Developmental Biology,General Medicine

Reference87 articles.

1. Toll-like receptor signalling in the intestinal epithelium: How bacterial recognition shapes intestinal function;Abreu;Nat. Rev. Immunol.,2010

2. Oncotherad immunotherapy elicits promising responses in Bacillus Calmette-Guérin-unresponsive non–muscle invasive bladder cancer: Results from phase I/ II study;Alonso;J. Clin. Oncol.,2020

3. Safety and Efficacy of OncoTherad Nano-immunotherapy in Patients with Non-Muscle Invasive Bladder Cancer;Alonso;J. Phys. Conf. Ser.,2021

4. World Cancer Report 2020;Bernard,2020

5. New Therapeutic Perspective for Bladder Cancer in Dogs: Toxicological and Clinical Effects of OncoTherad Nanostructured Immunotherapy;Böckelmann,2019

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of probiotic supplementation on chronic inflammatory process modulation in colorectal carcinogenesis;Tissue and Cell;2024-04

2. OncoTherad® (MRB-CFI-1) Nanoimmunotherapy: A Promising Strategy to Treat Bacillus Calmette–Guérin-Unresponsive Non-Muscle-Invasive Bladder Cancer: Crosstalk among T-Cell CX3CR1, Immune Checkpoints, and the Toll-Like Receptor 4 Signaling Pathway;International Journal of Molecular Sciences;2023-12-15

3. New synthetic nano-immunotherapy (OncoTherad®) for non-muscle invasive bladder cancer: Its synthesis, characterization and anticancer property;Tissue and Cell;2023-02

4. OncoTherad® is an immunomodulator of biological response that downregulate RANK/RANKL signaling pathway and PD-1/PD-L1 immune checkpoint in non-muscle invasive bladder cancer;Journal of Cancer Research and Clinical Oncology;2022-11-02

5. The Probiotic Strains Bifidοbacterium lactis, Lactobacillus acidophilus, Lactiplantibacillus plantarum and Saccharomyces boulardii Regulate Wound Healing and Chemokine Responses in Human Intestinal Subepithelial Myofibroblasts;Pharmaceuticals;2022-10-20